Second, A/A might prevent obesity by confronting the influences of inflammatory effects through the NF-κB pathways (42) and by lowering the production of lipopolysaccharide-induced NO release and inducible nitric oxide synthase and the expression of cyclooxygenases-2 (43). Here, NFKB1 is linked to obesity disorder.